期刊文献+

IL-17A单克隆抗体生物学活性检测方法的建立 被引量:1

Establishment of Analytical Method for Biological Activity of IL-17A Monoclonal Antibody
原文传递
导出
摘要 目的建立2种检测IL-17A单克隆抗体的生物学方法。方法(1)利用BIAcore T200系统,基于表面等离子共振技术(surface plasmob resonance,SPR)的分析方法检测IL-17A的生物学活性。(2)采用IL-6释放抑制法测定IL17-A单克隆抗体生物学活性。结果采用SPR法获得的偶联最佳pH值为5.0,动力学常数为0.10086 nmol·L^(-1),样品浓度为2.0625~33 nmol·L^(-1);IL-6释放抑制法检测的曲线拟合常数R2均满足>0.95,相对活性均在80%~125%,多次试验的RSD≤20%,满足重复性验证标准,符合要求。结论2种检测方法的结果均较好,可以有效地反映IL-17A的生物学活性,可以简单、快速用于检测IL^(-1)7A单克隆抗体生物活性。 OBJECTIVE To establish two analytical method to determine the biological activity of IL-17A monoclonal antibody.METHODS①The biological activity of IL-17A was detected by BIAcore T200 analysis method based on surface plasma resonance(SPR).②Determine the biological activity of IL-17A monoclonal antibody by IL-6 release inhibition method.RESULTS The optimum pH value of coupling obtained by SPR method was 5.0,the kinetic constant was 0.10086 nmol·L^(−1),and the sample concentration was 2.0625−33 nmol·L^(−1).The curve fitting constants R2 detected by IL-6 release inhibition method met the requirements of>0.95,the relative activity was 80%−125%,and the RSD of multiple tests was≤20%,which met the repeatability verification standard and met the requirements.CONCLUSION The results of the two detection methods are good,which can effectively reflect the biological activity of IL-17A,and can be used to detect the biological activity of IL-17A monoclonal antibody simply and quickly.
作者 陈莹莹 于秀梅 张驰 杨丽君 吴洁 李宛宸 郭常闰 CHEN Yingying;YU Xiumei;ZHANG Chi;YANG Lijun;WU Jie;LI Wanchen;GUO Changrun(TongHua DongBao Pharmaceutical Co.,Ltd.,Tonghua 134000,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2023年第6期808-811,共4页 Chinese Journal of Modern Applied Pharmacy
基金 吉林省科技发展计划项目(20190304040YY)。
关键词 IL-17A BIACORE 生物活性检测 单克隆抗体 IL-17A BIAcore biological activity test monoclonal antibody
  • 相关文献

参考文献5

二级参考文献21

  • 1Yarden Y. The EGFR family and its ligands in human cancer signalling mechanisms and therapeutic opportunities[J]. Eur J Cancer, 2001,37(4):3-8.
  • 2Gulliford T J, Huang G C, Ouyang X, et al. Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2[J]. Oncogene, 1997,15(18): 2219-2223.
  • 3Harari P M. Epidermal growth factor receptor inhibition strategies in oncology[J]. Endocr Relat Cancer, 2004,11(4):689-708.
  • 4EMEA. The initial scientific discussion for the approval of Erbitux[Z]. CHMP/8904/04, 2004.
  • 5Li S, Schmitz K R, Jeffrey P D, et al. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab [J]. Cancer Cell, 2005,7(4):301-311.
  • 6Fan Z, Masui H, Ahas I, et al. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies[J]. Cancer Res, 1993,53(18):4322-4328.
  • 7Kawamoto T, Sato J D, Le A, et al. Growth stimulation of A431 cells by epidermal growth factor:identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody[J]. Proc Natl Acad Sci USA, 1983,80 (5):1337-1341.
  • 8Gill G N, Kawamoto T, Cochet C, et al. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity[J]. J Biol Chem, 1984,259(12):7755-7760.
  • 9Dewe W. Review of statistical methodologies used to compare (bio)assays[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2009,877(23):2208-2213.
  • 10Overdijk M B, Verploegen S, Ortiz Buijsse A J, et al. Crosstalk between human IgG isotypes and murine effector cells[J]. J lmmunol, 2012,189(7):3430-3438.

共引文献32

同被引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部